ACTIVATION AND REGULATION OF NORMAL AND NEOPLASTIC CELLS

Information

  • Research Project
  • 3478978
  • ApplicationId
    3478978
  • Core Project Number
    R35CA039723
  • Full Project Number
    5R35CA039723-05
  • Serial Number
    39723
  • FOA Number
  • Sub Project Id
  • Project Start Date
    6/1/1987 - 37 years ago
  • Project End Date
    5/31/1993 - 31 years ago
  • Program Officer Name
  • Budget Start Date
    6/1/1990 - 34 years ago
  • Budget End Date
    5/31/1991 - 33 years ago
  • Fiscal Year
    1990
  • Support Year
    5
  • Suffix
  • Award Notice Date
    5/29/1990 - 34 years ago
Organizations

ACTIVATION AND REGULATION OF NORMAL AND NEOPLASTIC CELLS

The overall goal of the proposed research is to explore mechanisms of activation and regulation of function in normal and neoplastic cells. The studies involve (a) cytoplasmic control of cell replication, (b) modification of tumor cell properties by non-cytotoxic lymphokines, (c) regulation of lymphokine production and the expression of lymphokine activity, and (d) the effects of non-immunologic growth factors on the immune response. Studies in the first category are based on our observation that mitogen- or interleukin-activated normal lymphocytes contain a cytoplasmic protein (ADR) that can induce DNA synthesis in isolated nuclei in a cell-free system. We have also found that this factor is produced consitutively by neoplastic cells. We propose to investigate this regulatory system for cell proliferation by purifying ADR, studying the mechanisms involved in its reaction with the cell nucleus, and determining the abnormalities of ADR, nucleus, and inhibitory systems in neoplastic cells. Studies in the second category are based on the premise that modification of functional properties of tumor cells by immunologic mediators may be as useful a form of tumor therapy as the more commonly attempted strategies desighed to kill tumor cells. To this end, we are studying the ability of lymphokines to inhibit tumor cell migration and inhibit binding of tumor cells to endothelium, as well as the effects of lymphokines on other aspects of tumor cell behavior. Studies in the last two categories are designed to provide insight into novel ways in which immune regulation may be achieved, with special attention to lymphokine production and the expression of lymphokine activity. To this end, various immunologic regulatory macromolecules as well as hormonal growth and regulatory factors not generally considered to be part of the immune system will be investigated. Our overall approach for this aim involves the purification and characterization of responsible factors, elucidation of their mechanism of action, investigation of possible alterations in neoplastic states, and, ultimately, attempts to manipulate the systems in which they participate for possible therapeutic effort. It is hoped that these studies will provide insights into basic mechanisms of cell growth and regulation.

IC Name
NATIONAL CANCER INSTITUTE
  • Activity
    R35
  • Administering IC
    CA
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    396
  • Ed Inst. Type
    SCHOOLS OF MEDICINE
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SRC
  • Study Section Name
  • Organization Name
    HAHNEMANN UNIVERSITY
  • Organization Department
  • Organization DUNS
  • Organization City
    PHILADELPHIA
  • Organization State
    PA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    19129
  • Organization District
    UNITED STATES